199 related articles for article (PubMed ID: 10722120)
21. Identification of an adenosine receptor domain specifically involved in binding of 5'-substituted adenosine agonists.
Olah ME; Jacobson KA; Stiles GL
J Biol Chem; 1994 Jul; 269(27):18016-20. PubMed ID: 8027060
[TBL] [Abstract][Full Text] [Related]
22. Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain.
Vincenzi F; Pasquini S; Borea PA; Varani K
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218074
[TBL] [Abstract][Full Text] [Related]
23. Dominance of G(s) in doubly G(s)/G(i)-coupled chimaeric A(1)/A(2A) adenosine receptors in HEK-293 cells.
Tucker AL; Jia LG; Holeton D; Taylor AJ; Linden J
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):203-10. PubMed ID: 11062074
[TBL] [Abstract][Full Text] [Related]
24. Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms.
Jespers W; Schiedel AC; Heitman LH; Cooke RM; Kleene L; van Westen GJP; Gloriam DE; Müller CE; Sotelo E; Gutiérrez-de-Terán H
Trends Pharmacol Sci; 2018 Jan; 39(1):75-89. PubMed ID: 29203139
[TBL] [Abstract][Full Text] [Related]
25. Short term desensitization of the A1 adenosine receptors in DDT1MF-2 cells.
Nie Z; Mei Y; Ramkumar V
Mol Pharmacol; 1997 Sep; 52(3):456-64. PubMed ID: 9281608
[TBL] [Abstract][Full Text] [Related]
26. Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases.
Effendi WI; Nagano T; Kobayashi K; Nishimura Y
Cells; 2020 Mar; 9(3):. PubMed ID: 32213945
[TBL] [Abstract][Full Text] [Related]
27. Medicinal chemistry of adenosine A3 receptor ligands.
Müller CE
Curr Top Med Chem; 2003; 3(4):445-62. PubMed ID: 12570761
[TBL] [Abstract][Full Text] [Related]
28. The structure and function of A1 and A2B adenosine receptors.
Linden J; Auchampach JA; Jin X; Figler RA
Life Sci; 1998; 62(17-18):1519-24. PubMed ID: 9585129
[TBL] [Abstract][Full Text] [Related]
29. Involvement of mitogen protein kinase cascade in agonist-mediated human A(3) adenosine receptor regulation.
Trincavelli ML; Tuscano D; Marroni M; Klotz KN; Lucacchini A; Martini C
Biochim Biophys Acta; 2002 Aug; 1591(1-3):55-62. PubMed ID: 12183055
[TBL] [Abstract][Full Text] [Related]
30. Introduction to adenosine receptors as therapeutic targets.
Jacobson KA
Handb Exp Pharmacol; 2009; (193):1-24. PubMed ID: 19639277
[TBL] [Abstract][Full Text] [Related]
31. Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of GS alpha and Gi alpha are not associated with changes in their mRNAs.
Longabaugh JP; Didsbury J; Spiegel A; Stiles GL
Mol Pharmacol; 1989 Nov; 36(5):681-8. PubMed ID: 2511426
[TBL] [Abstract][Full Text] [Related]
32. Identification of threonine residues controlling the agonist-dependent phosphorylation and desensitization of the rat A(3) adenosine receptor.
Palmer TM; Stiles GL
Mol Pharmacol; 2000 Mar; 57(3):539-45. PubMed ID: 10692494
[TBL] [Abstract][Full Text] [Related]
33. Role of Adenosine Receptor(s) in the Control of Vascular Tone in the Mouse Pudendal Artery.
Labazi H; Tilley SL; Ledent C; Mustafa SJ
J Pharmacol Exp Ther; 2016 Mar; 356(3):673-80. PubMed ID: 26718241
[TBL] [Abstract][Full Text] [Related]
34. Structure-Based Rational Design of Adenosine Receptor Ligands.
Gutiérrez-de-Terán H; Sallander J; Sotelo E
Curr Top Med Chem; 2017; 17(1):40-58. PubMed ID: 27448653
[TBL] [Abstract][Full Text] [Related]
35. Adenosine receptors: new opportunities for future drugs.
Poulsen SA; Quinn RJ
Bioorg Med Chem; 1998 Jun; 6(6):619-41. PubMed ID: 9681130
[TBL] [Abstract][Full Text] [Related]
36. Machine Learning for Discovery of New ADORA Modulators.
Puhl AC; Gao ZG; Jacobson KA; Ekins S
Front Pharmacol; 2022; 13():920643. PubMed ID: 35814244
[TBL] [Abstract][Full Text] [Related]
37. Discovery of Novel Adenosine Receptor Antagonists through a Combined Structure- and Ligand-Based Approach Followed by Molecular Dynamics Investigation of Ligand Binding Mode.
Lagarias P; Vrontaki E; Lambrinidis G; Stamatis D; Convertino M; Ortore G; Mavromoustakos T; Klotz KN; Kolocouris A
J Chem Inf Model; 2018 Apr; 58(4):794-815. PubMed ID: 29485875
[TBL] [Abstract][Full Text] [Related]
38. Identification of an A2a adenosine receptor domain specifically responsible for mediating short-term desensitization.
Palmer TM; Stiles GL
Biochemistry; 1997 Jan; 36(4):832-8. PubMed ID: 9020781
[TBL] [Abstract][Full Text] [Related]
39. Molecular Dynamics Simulations of Adenosine Receptors: Advances, Applications and Trends.
Al-Shar'i NA; Al-Balas QA
Curr Pharm Des; 2019; 25(7):783-816. PubMed ID: 30834825
[TBL] [Abstract][Full Text] [Related]
40. In Silico Drug Design for Purinergic GPCRs: Overview on Molecular Dynamics Applied to Adenosine and P2Y Receptors.
Salmaso V; Jacobson KA
Biomolecules; 2020 May; 10(6):. PubMed ID: 32466404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
